Cuffless BP measurements could potentially provide significant value for clinicians and patients alike. It is still too early, however, for these technologies to be used in a clinical setting; too many unanswered questions remain.

Mario Gaudino, MD, PhD, spoke to Cardiovascular Business about minimally invasive procedures, the growing interest in clinical trials and other key trends in the world of cardiac surgery.

After years of trying to catch up with the competition, Boston Scientific is moving on. The company is no longer seeking approval from the FDA or any other regulatory agencies for these devices, and all global sales have been discontinued.

Remember when comprehensive checklists and human vigilance were going to end medical error? That hasn’t happened yet. AI might be able to help. 

Members of the U.S. House and Senate are proposing the Chiropractic Medicare Coverage Modernization Act, ensuring reimbursement for all medically necessary services.

Redwood City, California-based Prenuvo filed a formal complaint with the BBB National Programs' Advertising Division in response to the actions. 

The Marlborough, Mass., vendor rejected the offer from TPG and Blackstone but left the matter open to continued negotiations, according to the Financial Times. 

The Digital Medicine Society has partnered with organizations such as Duke University and Google Fitbit to leverage wearable technology and smartphone data in reducing opioid relapse and overdose deaths. As the pilot study gets underway, HealthExec speaks with Candice Taguibao, associate program director at the Digital Medicine Society, to learn more about the initiative.

Healthcare AI can add considerable value to patient care practices, but it can also “just add noise to an already complex system.” 

The shift follows a paper published by the FDA in the New England Journal of Medicine last week, outlining a stricter framework for approving annual COVID-19 boosters and future vaccines.